Heckenberger R, Schrör K
Institut für Pharmakologie, Heinrich-Heine-Universität Düsseldorf, FRG.
Eicosanoids. 1992;5 Suppl:S23-5.
This study investigates the significance of PMN-derived LTB4 for PMN activation by using a selective LTB4 antagonist (SC 41930). Human PMN were stimulated by platelet-activating-factor (PAF, 3 microM), a receptor dependent agonist, or by calcimycin (A 23187, 10 microM), a receptor independent agonist. PMN activation was determined by LTB4 release and changes in free cytosolic Ca++ levels. Pretreatment of the PMN with SC 41930 (0.1-10 microM) caused a concentration-dependent inhibition of agonist induced rise in cytosolic Ca++ with both PAF and calcimycin. Interestingly, at the same concentrations of SC 41.930, there was a concentration-dependent inhibition of LTB4 release. Control experiments with a cell-free 5-lipoxygenase preparation did not show any direct effect of SC 41930 on the enzyme under conditions when nordihydroguiaretic acid was active. The data demonstrate a nonselective inhibition of agonist induced PMN activation by the LTB4 receptor antagonist SC 41930 and suggest that formation of endogenous LTB4 is involved in a positive feed-back loop that is required for maximum stimulation of PMN function even by a calcium ionophore.
本研究通过使用选择性白三烯B4拮抗剂(SC 41930)来探究中性粒细胞衍生的白三烯B4对中性粒细胞激活的意义。人中性粒细胞由血小板激活因子(PAF,3微摩尔)(一种受体依赖性激动剂)或离子霉素(A 23187,10微摩尔)(一种受体非依赖性激动剂)刺激。通过白三烯B4释放和游离胞浆钙离子水平变化来测定中性粒细胞激活。用SC 41930(0.1 - 10微摩尔)预处理中性粒细胞导致PAF和离子霉素诱导的胞浆钙离子升高呈浓度依赖性抑制。有趣的是,在相同浓度的SC 41.930下,白三烯B4释放呈浓度依赖性抑制。在去甲二氢愈创木酸有活性的条件下,使用无细胞5 - 脂氧合酶制剂进行的对照实验未显示SC 41930对该酶有任何直接作用。数据表明白三烯B4受体拮抗剂SC 41930对激动剂诱导的中性粒细胞激活有非选择性抑制作用,并提示内源性白三烯B4的形成参与了一个正反馈回路,即使对于钙离子载体,该回路也是最大程度刺激中性粒细胞功能所必需的。